参考文献/References:
[1] Papazafiropoulou A, Sotiropoulos A, Kokolaki A,et al. Prevalence of thyroid dysfunction among Greek type 2 diabetic patients attending an outpatient clinic[J].J Clin Med Res, 2010,2(2):75-78. DOI: 10.4021/jocmr2010.03.281w.
[2] Arya S, Shah B, Arya IN, et al. An elucidatory review of the association between thyroid disorders and diabetes[J]. Int J Med Sci Public Health, 2013,2(4):797-800. DOI:10.5455/ijmsph.2013.010920133.
[3] Chen HS, Wu TE, Jap TS,et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in type 2 diabetic patients[J].Diabet Med,2007,24(12):1336-1344. DOI:10.1111/j.1464-5491.2007.02270.x.
[4] Furukawa S, Yamamoto S, Todo Y, et al. Association between subclinical hypothyroidism and diabetic nephropathy in patients with type 2 diabetes mellitus[J].Endocr J,2014,61(10):1011-1018.
[5] 邵芬,李晓行,章臻翊,等.亚临床甲状腺功能减退与2型糖尿病慢性并发症的相关性[J].医学临床研究,2014,31(7):1291-1293. DOI:10.3969/j.issn.1671-7171.2014.07.015.
[6] 徐静,朱凤.亚临床甲状腺功能减退症与2 型糖尿病微血管并发症关系的研究[J].中国实用医药,2015,10(34):100-101.DOI:10.14163/j.cnki.11-5547/r.2015.34.071.
[7] Ramis JN, Artigas CF, Santiago MA,et al. Is there a relationship between TSH levels and diabetic retinopathy in the Caucasian population[J].Diabetes Res Clin Pract,2012,97(3):e45-e47. DOI: 10.1016/j.diabres.2012.05.015.
[8] Yang JK, Liu W, Shi J,et al. An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients[J].Diabetes Care,2010,33(5):1018-1020. DOI: 10.2337/dc09-1784.
[9] Yang GR, Yang JK, Zhang L, et al. Association between subclinical hypothyroidism and proliferative diabetic retinopathy in type 2 diabetic patients: a case-control study[J].Tohoku J Exp Med,2010,222(4):303-310.
[10] Kim BY, Kim CH, Jung CH,et al. Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2 diabetes[J].Endocr J,2011,58(12):1065-1070.
[11] Wu J, Yue S, Geng J, et al. Relationship between diabetic retinopathy and subclinical hypothyroidism: a meta-analysis[J].Sci Rep,2015,5:12212. DOI: 10.1038/srep12212.
[12] Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction[J].Clin Sci(Lond),2005,109(2):143-159. DOI:10.1042/CS20050025.
[13] 陈晖, 郭媛.2型糖尿病视网膜病变患者检测HCY和血流变学指标的意义[J].海南医学院学报,2012,18(3):325-326.DOI:10.13210/j.cnki.jhmu.2012.03.028.
[14] Sen U, Pushpakumar SB, Amin MA, et al. Homocysteine in renovascular complications: hydrogen sulfide is a modulator and plausible anaerobic ATP generator[J].Nitric Oxide,2014,41:27-37. DOI: 10.1016/j.niox.2014.06.006.
[15] Sieber J, Lindenmeyer MT, Kampe K, et al. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids[J].Am J Physiol Renal Physiol,2010,299(4):F821-F829. DOI: 10.1152/ajprenal.00196.2010.
[16] Chung JJ, Huber TB, Gödel M, et al. Albumin-associated free fatty acids induce macropinocytosis in podocytes[J].J Clin Invest, 2015,125(6):2307-2316. DOI: 10.1172/JCI79641.
[17] 陈辉雄,张丽萍, 陈玉华.探讨同型半胱氨酸、血脂及血液流变学在糖尿病视网膜病变中的意义[J].检验医学与临床,2014,11(9):1179-1181.DOI:10.3969/j.issn.1672-9455.2014.09.012.
[18] Kvetny J, Heldgaard PE, Bladbjerg EM,et al. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years[J].Clin Endocrinol(Oxf),2004,61(2):232-238. DOI:10.1111/j.1365-2265.2004.02088.x.
[19] Mahto M, Chakraborthy B, Gowda SH,et al. Are hsCRP levels and LDL/HDL ratio better and early markers to unmask onset of dyslipidemia and inflammation in asymptomatic subclinical hypothyroidism [J].Indian J Clin Biochem,2012,27(3):284-289. DOI: 10.1007/s12291-012-0206-y.
[20] You YK, Huang XR, Chen HY, et al. C-Reactive protein promotes diabetic kidney disease in db/db mice via the CD32b-Smad3-mTOR signaling pathway[J].Sci Rep,2016,6:26740. DOI: 10.1038/srep26740.
[21] Muni RH, Kohly RP, Lee EQ,et al. Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control andcomplications trial[J].JAMA Ophthalmol,2013,131(4):514-521. DOI: 10.1001/jamaophthalmol.2013.2299.
[22] Ceki S, Cvetkovi T, Jovanovi I, et al. C-reactive protein and chitinase 3-like protein 1 as biomarkers of spatial redistribution of retinal blood vessels on digital retinal photography in patients with diabetic retinopathy[J].Bosn J Basic Med Sci,2014,14(3):177-184. DOI: 10.17305/bjbms.2014.3.21.
[23] Gen R, Akbay E, Sezer K. Insulin resistance and cardiovascular risk factors in patients with mild and severe subclinical hypothyroidism[J]. Endocrinologist, 2010, 20(3):128-130.DOI:10.1097/TEN.0b013c3181dfc618.
[24] Forst T, Weber MM, Mitry M, et al. Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitus[J].J Diabetes Sci Technol,2012,6(1):163-168.
[25] Singer MA. Of mice and men and elephants: metabolic rate sets glomerular filtration rate[J].Am J Kidney Dis,2001,37(1):164-178.
[26] 刘光政.有关亚临床甲状腺功能减退与糖尿病慢性并发症的相关性探究[J].大家健康,2013,7(6):105-106.
[27] Imig JD, Ryan MJ. Immune and inflammatory role in renal disease[J].Compr Physiol,2013,3(2):957-976. DOI: 10.1002/cphy.c120028.
[28] Hu Y, Liu F, Shen J, et al. Association between serum cystatin C and diabetic peripheral neuropathy: a cross-sectional study of a Chinese type 2 diabetic population[J].Eur J Endocrinol, 2014,171(5):641-648. DOI: 10.1530/EJE-14-0381.
[29] Rizos CV, Elisaf MS, Liberopoulos EN. Effects of thyroid dysfunction on lipid profile[J].Open Cardiovasc Med J,2011,5:76-84.DOI: 10.2174/1874192401105010076.
[30] Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality[J].JAMA,2010,304(12):1365-1374. DOI: 10.1001/jama.2010.1361.
[31] Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction[J].Endocr Rev,2008,29(1):76-131. DOI:10.1210/er.2006-0043.
[32] Klein I, Danzi S. Thyroid disease and the heart[J].Circulation,2007,116(15):1725-1735. DOI:10.1161/CIRCULATIONAHA.106.678326.
[33] 王敬军.糖尿病合并亚临床甲状腺功能减退症的研究进展[J]. 医疗装备,2015(7):43-44 DOI:10.3969/j.issn.1002-2376.2015.07.020.
[34] 田林玉.亚临床甲状腺功能减退症与2型糖尿病及其慢性并发症相关性研究进展[J] 医学综述,2015,21(21):3938-3941. DOI:10.3969/j.issn.1006-2084.2015.21.034.
[35] Dessein PH, Joffe BI, Stanwix AE. Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis[J].Thyroid,2004,14(6):443-446. DOI:10.1089/105072504323150750.
[36] Lee SW, Cho KI, Kim HS,et al. The impact of subclinical hypothyroidism or thyroid autoimmunity on coronary vasospasm in patients without associated cardiovascular risk factors[J].Korean Circ J,2015,45(2):125-130. DOI: 10.4070/kcj.2015.45.2.125.
[37] Mya MM, Aronow WS. Increased prevalence of peripheral arterial disease in older men and women with subclinical hypothyroidism[J].J Gerontol A Biol Sci Med Sci,2003,58(1):68-69.
相似文献/References:
[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]李翠柳,朱大龙.破译肠道代谢信息,驱动治疗革新[J].国际内分泌代谢杂志,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
Li Cuiliu*,Zhu Dalong..Deciphering metabolic messages from the gut drives therapeutic innovation[J].International Journal of Endocrinology and Metabolism,2014,(01):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
[10]袁捷 姜云生 杜彦丽 王肃.1型糖尿病对小鼠早孕时期子宫肌层结构和细胞增殖的影响[J].国际内分泌代谢杂志,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
Yuan JieJiang YunshengDu YanliWang Su.Effects of type 1 diabetes on the muscularis structure and cell proliferation of uterine in mice during early pregnancy[J].International Journal of Endocrinology and Metabolism,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]